/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
Burlington, North Carolina-based Labcorp Holdings Inc. (LH) operates as a laboratory services company, providing information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. With a market cap of nearly $20 billion, the company operates through diagnostics laboratories (Dx) and biopharma laboratory services (BLS) segments. Labcorp is set to announce its fourth-quarter results before the markets open on Thursday, Feb. 6.
Ahead of the event, analysts expect LH to report a non-GAAP profit of $3.40 per share, up a modest 3% from $3.30 per share reported in the year-ago quarter. Furthermore, the company has surpassed Wall Street’s bottom-line projections in each of the past four quarters. Its adjusted EPS for the last reported quarter increased 3.6% year-over-year to $3.50, marginally exceeding analysts’ expectations.